Transgene Biotek Ltd

NSE: TRABI · BSE: 526139 · Healthcare · 4 announcements

Share price: ₹2.60
Market cap: ₹19.70 Cr
Revenue (annual): ₹0.21 Cr
Net profit (annual): ₹-1.65 Cr
P/E (TTM): -12.2×Sector 57.8×
Promoter holding: 23.64%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

25 Sep 2026 11:53 IST BSE

Annual General Meeting

Transgene Biotek Annual General Meeting

Transgene Biotek has received ROC approval to extend its 36th AGM deadline by three months. The meeting for FY2025-26 will now be held by December 31, 2026.

Read the filing ↗